ConductScience.org, home

Paper475369

In vitro of cefotaxime against cephalothin-resistant clinical isolates.

Van Landuyt HW and 1 other. Antimicrob Agents Chemother, 1979. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. In vitro of cefotaxime against cephalothin-resistant clinical isolates. Papers, record 475369. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/475369

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vitro of cefotaxime against cephalothin-resistant clinical isolates.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1979
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
1.4
iCite
Revised in PubMed
2021-05-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Van Landuyt HWH W
2Pyckavet MM

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BacteriaMajor topic
CephalosporinsMajor topic
CephalothinMajor topic
EnterobacteriaceaeMajor topic
Drug Resistance, Microbial
Haemophilus
Pseudomonas

Source PubMed

Download CSV of topics

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1101128beta-lactamase stability of HR 756, a novel cephalosporin, compared to that of cefuroxime and cefoxitin.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/101128PubMed
2413795Experimental evaluation of HR756, a new cephalosporin derivative: pre-clinical study.Infection1977https://conductscience.org/library/papers/413795PubMed
3308506Activity of HR 756 against Haemophilus influenzae, Bacteroides fragilis and Gram-negative rods.J Antimicrob Chemother1978https://conductscience.org/library/papers/308506PubMed
4308505Cefotoxime (HR 756) a new cephalosporin with exceptional broad-spectrum activity in vitro.J Antimicrob Chemother1978https://conductscience.org/library/papers/308505PubMed
5984801Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/984801PubMed
64210609Antibiotic susceptibility of gram-negative bacilli isolated from blood cultures. Results of tests with 35 agents and strains from 169 patients at Boston City Hospital during 1972.Am J Med1974https://conductscience.org/library/papers/4210609PubMed
74546094Haemophilus influenzae type B resistant to ampicillin. A report of two cases.JAMA1974https://conductscience.org/library/papers/4546094PubMed
84840447Cefoxitin, a semisynthetic cephamycin antibiotic: susceptibility studies.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4840447PubMed
94790616Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4790616PubMed
101259407Cefuroxime, a new cephalosporin antibiotic: activity in vitro.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/1259407PubMed
11938029In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/938029PubMed
121137364Susceptibility of anaerobes to cefoxitin and other cephalosporins.Antimicrob Agents Chemother1975https://conductscience.org/library/papers/1137364PubMed

Download CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
6995096The cephalosporins: activity and clinical use.Drugs1980https://conductscience.org/library/papers/6995096PubMed
6313487Penetration of cefotaxime into the aqueous humour of the human eye after intravenous application.Graefes Arch Clin Exp Ophthalmol1983https://conductscience.org/library/papers/6313487PubMed
6282202Clinical efficacy of cefotaxime in serious infections.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6282202PubMed
6282198Serum bactericidal activity of moxalactam and cefotaxime with and without tobramycin against Pseudomonas aeruginosa and Staphylococcus aureus.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6282198PubMed
6275784Cefmenoxime (SCE-1365), a new cephalosporin: in vitro activity, comparison with other antimicrobial agents, beta-lactamase stability, and disk diffusion testing with tentative interpretive criteria.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6275784PubMed
6252832In vitro activities of cefotaxime and moxalactam (LY127935) against Haemophilus influenzae.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6252832PubMed
6252831Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6252831PubMed
6251750Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6251750PubMed
6251749In vitro antimicrobial activity of cefotaxime, a new cephalosporin.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6251749PubMed
2073095
Comparative in vitro activities of amoxicillin-clavulanic acid, cefuroxime, cephalexin, and cephalothin against trimethoprim-resistant Escherichia coli isolated from stools of children attending day-care centers.
Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2073095PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/475369

GET https://conductscience.org/api/papers/v1/475369/authors